David Vesole, MD
Medical Oncology · Hackensack, NJNPI 1790773356
Payments from drug & device makers
Across 855 payments — averaging $3514.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1.3M
- Sanofi$387K
- Amgen$347K
- Johnson & Johnson$222K
- GSK$187K
- Janssen Research & Development, LLC$152K
- plus $438K from 22 others
Across 22 payments — averaging $4689.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ichnos Glenmark Innovation Inc$85K
- Takeda Pharmaceuticals U.S.A., Inc.$12K
- Pfizer$5K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 91 | $1,272,206 |
| Sanofi | 62 | $386,732 |
| Amgen | 88 | $347,112 |
| Johnson & Johnson(2 entities) | 265 | $221,831 |
| GSK | 76 | $186,700 |
| Janssen Research & Development, LLC | 41 | $151,912 |
| Takeda Pharmaceuticals U.S.A., Inc. | 85 | $133,210 |
| Sanofi US Services Inc. | 9 | $63,040 |
| Vanda Pharmaceuticals Inc. | 3 | $50,550 |
| Karyopharm Therapeutics Inc. | 34 | $50,380 |
| E.r. Squibb & Sons, L.L.C. | 16 | $40,616 |
| Pharmacyclics LLC, An Abbvie Company | 20 | $35,775 |
| AbbVie | 7 | $22,347 |
| EMD Serono, Inc. | 1 | $17,375 |
| Bristol Myers Squibb | 28 | $12,796 |
| Omeros Corporation | 1 | $3,800 |
| Secura Bio, Inc. | 2 | $3,352 |
| Adaptive Biotechnologies Corporation | 5 | $2,250 |
| Janssen Scientific Affairs, LLC | 2 | $1,260 |
| Menarini Silicon Biosystems, Inc. | 1 | $500 |
| Beigene, Ltd. | 1 | $450 |
| Legend Biotech USA Inc. | 3 | $235 |
| Novartis | 3 | $73 |
| Sanofi-aventis U.S. LLC | 2 | $63 |
| Incyte Corporation | 1 | $26 |
| Astellas Pharma US Inc | 1 | $20 |
| Gilead | 1 | $17 |
| Cornerstone Specialty Network LLC | 6 | $0 |
How this compares
$3,004,627 in reported general payments places this provider in the 85th percentile of 112 medical oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Hackensack
- Martin GutierrezHackensack$41.8M
- James McCloskeyHackensack$17.1M
- Lori LeslieHackensack$11.9M
- Tatyana FeldmanHackensack$8.4M
- David SiegelHackensack$6.9M
- Noa BiranHackensack$5.8M
- Andrew PecoraHackensack$4.5M
- Robert AlterHackensack$4.5M
- Jamie KoprivnikarHackensack$3.8M
- Deena GrahamHackensack$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.